Advertisement
U.S. Markets open in 3 hrs 51 mins
S&P Futures
6,002.25 -1.50 (-0.02%) Dow Futures
43,896.00 -14.00 (-0.03%) Nasdaq Futures
21,196.00 -28.75 (-0.14%) Russell 2000 Futures
2,395.00 -0.70 (-0.03%) Crude Oil
71.08 -1.28 (-1.77%) Gold
2,692.10 -13.70 (-0.51%)
22S.BE,0P0001KHHM,0 (22S.BE)
Berlin - Berlin Delayed Price. Currency in EUR
Follow
As of 09:00PM CET. Market open.
| Previous Close | 0.0000 |
| YTD Return | N/A |
| Expense Ratio (net) | N/A |
| Category | N/A |
| Last Cap Gain | N/A |
| Morningstar Rating | N/A |
| Morningstar Risk Rating | N/A |
| Sustainability Rating | N/A |
| Net Assets | N/A |
| Beta (5Y Monthly) | N/A |
| Yield | N/A |
| 5y Average Return | N/A |
| Holdings Turnover | N/A |
| Last Dividend | N/A |
| Average for Category | N/A |
| Inception Date | N/A |
GlobeNewswireNuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds
MINNEAPOLIS, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company committed to transforming the lives of people with fluid overload, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants issued by the Company on April 30, 2024 (collectively, the “Existing Warrants”) to purchase up to an aggregate of 1,832,517 shares of the Company’s common stock at their c
GuruFocus.comNuwellis Stock Soars 121% on Major Increase in Reimbursement for Aquadex System
Nuwellis' Aquadex System Receives Significant Reimbursement Increase
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.